Diabetes
55:70-77,
2006
DOI: 10.2337/diabetes.55.01.06.db05-0632
© 2006 by the American Diabetes Association
Evaluation of ß-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental LactogenComprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip
Irene Cozar-Castellano,
Matthew Weinstock,
Marcia Haught,
Silvia Velázquez-Garcia,
Darinka Sipula, and
Andrew F. Stewart
Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Address correspondence and reprint requests to Irene Cozar-Castellano, PhD, Division of Endocrinology, BST E-1140, University of Pittsburgh School of Medicine, 200 Lothrop St., Pittsburgh, PA 15213. E-mail: cozari{at}dom.pitt.edu
Abbreviations:
CIP, cyclin inhibitory protein; HGF, hepatocyte growth factor; INK, inhibitory kinase; KIP, kinase inhibitory protein; PTHrP, parathyroid hormone–related protein; RIP, rat insulin promoter; RIP-PL, RIP-placental lactogen
We hypothesized that combined transgenic overexpression of hepatocyte growth factor (HGF) and placental lactogen in islets would lead to even greater increases in ß-cell mass and replication than either growth factor alone. This did not occur, suggesting that ß-cell replication is saturable or subject to molecular restraint. We therefore performed the first comprehensive G1/S cell cycle survey in islets, cataloguing the broad range of kinases, cyclins, and kinase inhibitors that control the G1/S transition in islets from normal, HGF, placental lactogen, and doubly transgenic mice. Many of the G1/S checkpoint regulators (E2Fs; pRb; p107; p130; cyclins D1,2,3, A, and E; cdk-2; cdk-4; p15; p16; p18; p19; p21; p27; MDM2; p53; c-Myc; and Egr-1) are present in the murine islet. Most of these proteins were unaltered by overexpression of HGF or placental lactogen, either alone or in combination. In contrast, p21cip was uniquely, dramatically, and reproducibly upregulated in placental lactogen and HGF islets. p21cip was also present in, and upregulated in, proliferating human islets, localizing specifically in ß-cells and translocating to the nucleus on mitogenic stimulation. Homozygous p21cip loss releases islets from growth inhibition, markedly enhancing proliferation in response to HGF and placental lactogen.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. C. Alonso, T. Yokoe, P. Zhang, D. K. Scott, S. K. Kim, C. P. O'Donnell, and A. Garcia-Ocana
Glucose Infusion in Mice: A New Model to Induce {beta}-Cell Replication
Diabetes,
July 1, 2007;
56(7):
1792 - 1801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol.,
February 1, 2007;
38(2):
193 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart
Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function
Diabetes,
January 1, 2007;
56(1):
57 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cozar-Castellano, M. Haught, and A. F. Stewart
The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo
Diabetes,
December 1, 2006;
55(12):
3271 - 3278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart
Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell
Endocr. Rev.,
June 1, 2006;
27(4):
356 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamada, H. Ishihara, A. Tamura, R. Takahashi, S. Yamaguchi, D. Takei, A. Tokita, C. Satake, F. Tashiro, H. Katagiri, et al.
WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic {beta}-cells
Hum. Mol. Genet.,
May 15, 2006;
15(10):
1600 - 1609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Luo, S. M. Liu, H. Liu, Q. Li, Q. Xu, X. Sun, B. Davis, J. Li, and S. Chua Jr.
Allelic Variation on Chromosome 5 Controls {beta}-Cell Mass Expansion during Hyperglycemia in Leptin Receptor-Deficient Diabetes Mice
Endocrinology,
May 1, 2006;
147(5):
2287 - 2295.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|